Two Sigma Investments’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-4,300
Closed -$394K 4269
2021
Q2
$394K Buy
4,300
+400
+10% +$31.8K ﹤0.01% 3293
2021
Q1
$266K Buy
+3,900
New +$303K ﹤0.01% 3423

Other funds holding CDNA

Two Sigma Investments's CDNA Position: Q1 2026 in Review

Two Sigma Investments increased its CareDx (CDNA) stake by 159% in Q1 2026, buying an estimated $2.69M and bringing the position to 231,600 shares worth $4.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2165.

Two Sigma Investments first reported a position in CDNA in Q4 2017 and has held it in 31 quarters since. The position peaked at $26.6M in Q1 2021. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

  • Two Sigma Investments held 231,600 shares of CareDx worth $4.02M as of Q1 2026.
  • Two Sigma Investments bought 142,300 CareDx shares in Q1 2026, an estimated $2.69M.
  • CareDx made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #2165 holding.
  • Two Sigma Investments first reported a position in CareDx in Q4 2017 and has held it in 31 quarters since.
  • Two Sigma Investments's CareDx position peaked at $26.6M in Q1 2021.
  • 190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.